🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, dose-E...
Status
Completed
Location
Allife Medicine （Beijing） Limitied
Start Date
2023-08-24
Trial ID
NCT05993884
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
This is a phase 1/2a study in dentin hypersensitivity patients to assess th...
Status
Completed
Location
Seoul National University Dental Hospital
Start Date
2021-06-14
Trial ID
NCT04804514
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested